Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure–activity relationship studies
- 1 March 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (5) , 1509-1513
- https://doi.org/10.1016/j.bmcl.2004.12.068
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Strategies in the design of antiviral drugsNature Reviews Drug Discovery, 2002
- Antiviral drugs: current state of the artJournal of Clinical Virology, 2001
- Protease Inhibitors: Current Status and Future ProspectsJournal of Medicinal Chemistry, 2000
- Recent developments in HIV protease inhibitor therapyAntiviral Research, 1998
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- Molecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignChemical Reviews, 1997
- The discovery, characterization and crystallographically determined binding mode of an FMOC-containing inhibitor of HIV-1 proteaseBioorganic & Medicinal Chemistry, 1997
- Section Reviews; Anti-infectives: Section Review Anti-infectives: HIV protease inhibitors in early developmentExpert Opinion on Investigational Drugs, 1996
- Novel Fluorogenic Substrates for Assaying Retroviral Proteases by Resonance Energy TransferScience, 1990
- A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle MaturationScience, 1990